HighTower Advisors
SNY icon

HighTower Advisors’s Sanofi SNY Stock Holding History

HighTower Advisors’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,000
Closed -$3K – 2346
2017
Q2 		$3K Buy
+1,000
New +$47.8K ﹤0.01% 2171

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

HighTower Advisors's SNY Position: Q1 2026 in Review

HighTower Advisors reduced its Sanofi (SNY) stake by 12% in Q1 2026, selling an estimated $393K and leaving 64,096 shares worth $3.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1456.

HighTower Advisors first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $17M in Q3 2023. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • HighTower Advisors held 64,096 shares of Sanofi worth $3.09M as of Q1 2026.
  • HighTower Advisors sold 8,436 Sanofi shares in Q1 2026, an estimated $393K.
  • Sanofi made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #1456 holding.
  • HighTower Advisors first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Sanofi position peaked at $17M in Q3 2023.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.